Piper Sandler & Co’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-800
Closed -$10K 200
2014
Q2
$10K Buy
+800
New +$6.49K 0.01% 110

Other funds holding RNA

Piper Sandler & Co's RNA Position: Q3 2014 in Review

Piper Sandler & Co sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q3 2014, closing a stake of 800 shares — an estimated $10K sold.

Piper Sandler & Co first reported a position in RNA in Q2 2014 and held it in 1 quarter. The position peaked at $10K in Q2 2014. 32 funds tracked by Wall St. Rank hold RNA as of Q3 2014.

  • Piper Sandler & Co reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q3 2014 after selling out during the quarter.
  • Piper Sandler & Co sold 800 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q3 2014, an estimated $10K.
  • Piper Sandler & Co first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q2 2014 and held it in 1 quarter.
  • Piper Sandler & Co's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $10K in Q2 2014.
  • 32 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q3 2014.

Based on Piper Sandler & Co's 13F filing for Q3 2014, filed 14 Nov 2014.